Anna Jewell
Tracked across 1 events · 74 articles · First seen May 29, 2026 · Last active Jun 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Anna Jewell, director at Pancreatic_Cancer_UK, emphasized the excitement surrounding new treatments targeting KRAS mutations and called for fast-tracking their approval in the United Kingdom.
May 29, 2026 · 74 articles
ERGEN INTELLIGENCE
Track Anna Jewell live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard